{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:45Z","timestamp":1787026845909,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Universit\u00e0 Politecnica delle Marche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    Some evidence suggests a possible influence of liver disease on stroke prognosis. We investigated the association between fibrosis-4 (FIB-4) score, a marker of liver disease, and the 3-month outcome in patients with ischemic stroke undergoing intravenous thrombolysis. We also evaluated the rate of symptomatic intracranial hemorrhage after thrombolysis. In this prospective cohort study, we enrolled consecutive patients with ischemic stroke treated with thrombolysis who had a 3-month follow-up. The FIB-4 score was calculated and the validated cut-off values were used to indicate high\/low risk of advanced liver fibrosis. The primary outcome was 3-month poor prognosis estimated as a modified Rankin scale score \u22653. Of the 264 included patients, 131 (49.62%) had a 3-month mRS \u22653, with a significantly higher FIB-4 score, compared to those with a mRS &amp;lt;3 score (\n                    <jats:sub>adj<\/jats:sub>\n                    p &amp;lt;0.001). When adjusted for possible confounders by multivariate logistic regression, FIB-4 score remained a significant predictor of poor outcome (OR 1.894,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.011), along with history of atrial fibrillation (OR 3.488,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.017), admission NIHSS score (OR 1.305,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001), and low values of hemoglobin (OR 0.730,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001). Mechanical thrombectomy had a favorable effect on patients' outcome (OR 0.201,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.005). The risk of poor 3-month outcome was significantly higher among the 32 patients (12.1%) with high risk of severe fibrosis (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.007). FIB-4 score values were also related to symptomatic intracranial hemorrhage (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.004), specifically among patients with high probability of advanced hepatic fibrosis (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.037). FIB-4 score can be considered as a promising independent predictor of poor prognosis in patients with acute ischemic stroke undergoing intravenous thrombolysis.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2023.1103063","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T08:30:20Z","timestamp":1677227420000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Liver fibrosis-4 score predicts outcome of patients with ischemic stroke undergoing intravenous thrombolysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Davide","family":"Norata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Silvestrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/1747493019881353","article-title":"World stroke organization (WSO): global stroke fact sheet 2019","volume":"14","author":"Lindsay","year":"2019","journal-title":"Int J Stroke."},{"key":"B2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron."},{"key":"B3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(15)00054-X","article-title":"Future directions of acute ischaemic stroke therapy","volume":"14","author":"Fisher","year":"2015","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1161\/hs1201.99821","article-title":"Time course of tissue plasminogen activator\u2013induced recanalization in acute cardioembolic stroke: a case-control study","volume":"32","author":"Molina","year":"2001","journal-title":"Stroke."},{"key":"B5","doi-asserted-by":"publisher","first-page":"18524","DOI":"10.1038\/s41598-020-75609-1","article-title":"Endovascular treatment and cognitive outcome after anterior circulation ischemic stroke","volume":"10","author":"Lattanzi","year":"2020","journal-title":"Sci Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1001\/jama.2018.17365","article-title":"Diagnosis and management of nonalcoholic fatty liver disease","volume":"320","author":"Paul","year":"2018","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jhep.2013.10.017","article-title":"Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study","volume":"60","author":"Morling","year":"2014","journal-title":"J Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12072-015-9690-5","article-title":"High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease","volume":"10","author":"Xu","year":"2016","journal-title":"Hepatol Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2017.03.028","article-title":"Ischaemic stroke and liver fibrosis","volume":"260","author":"Walker","year":"2017","journal-title":"Atherosclerosis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"116524","DOI":"10.1016\/j.jns.2019.116524","article-title":"Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke","volume":"407","author":"Parikh","year":"2019","journal-title":"J Neurol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000497069","article-title":"Liver fibrosis, not steatosis, associates with long-term outcomes in ischaemic stroke patients","volume":"47","author":"Baik","year":"2019","journal-title":"Cerebrovasc Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3389\/fneur.2020.00867","article-title":"Liver fibrosis is associated with hemorrhagic transformation in patients with acute ischemic stroke","volume":"11","author":"Yuan","year":"2020","journal-title":"Front Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","article-title":"Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies","volume":"43","author":"Whiteley","year":"2012","journal-title":"Stroke."},{"key":"B15","first-page":"144","article-title":"Association between non-alcoholic fatty liver disease and ischemic stroke","volume":"13","author":"Moshayedi","year":"2014","journal-title":"Iran J Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"175628642110372","DOI":"10.1177\/17562864211037239","article-title":"Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke","volume":"14","author":"Fandler-H\u00f6fler","year":"2021","journal-title":"Ther Adv Neurol Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/01.STR.25.2.362","article-title":"Serial assessment of acute stroke using the NIH Stroke Scale","volume":"25","author":"Wityk","year":"1994","journal-title":"Stroke."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/2050640619865133","article-title":"Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease","volume":"7","author":"Staufer","year":"2019","journal-title":"United Eur Gastroenterol J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1161\/STR.0000000000000152","article-title":"Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Yaghi","year":"2017","journal-title":"Stroke."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1161\/STROKEAHA.114.007564","article-title":"Twenty-year history of the evolution of stroke thrombolysis with intravenous alteplase to reduce long-term disability","volume":"46","author":"Campbell","year":"2015","journal-title":"Stroke."},{"key":"B23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.22088\/cjim.10.4.424","article-title":"Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration","volume":"10","author":"Mehrpour","year":"2019","journal-title":"Casp J Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1073267","DOI":"10.3389\/fnagi.2022.1073267","article-title":"Impact of glycosylated hemoglobin on early neurological deterioration in acute mild ischemic stroke patients treated with intravenous thrombolysis","volume":"14","author":"Han","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0139227","DOI":"10.1371\/journal.pone.0139227","article-title":"Relationship between cerebral microbleeds and liver stiffness determined by transient elastography","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.atherosclerosis.2015.02.011","article-title":"The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"239","author":"Al Rifai","year":"2015","journal-title":"Atherosclerosis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1464-5491.2005.01646.x","article-title":"Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue","volume":"22","author":"Targher","year":"2005","journal-title":"Diabet Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.metabol.2016.11.004","article-title":"Association between vascular inflammation and non-alcoholic fatty liver disease: analysis by 18F-fluorodeoxyglucose positron emission tomography","volume":"67","author":"Lee","year":"2017","journal-title":"Metabolism."},{"key":"B29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study","volume":"63","author":"Mellinger","year":"2015","journal-title":"J Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.atherosclerosis.2014.05.962","article-title":"Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study","volume":"235","author":"VanWagner","year":"2014","journal-title":"Atherosclerosis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/gutjnl-2016-311854","article-title":"Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study","volume":"66","author":"Sinn","year":"2017","journal-title":"Gut."},{"key":"B32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/hep.28253","article-title":"Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: a prospective cohort study","volume":"63","author":"Wong","year":"2016","journal-title":"Hepatol Baltim Md."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/MEG.0000000000000429","article-title":"Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis","volume":"27","author":"Madan","year":"2015","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0184646","DOI":"10.1371\/journal.pone.0184646","article-title":"Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"104360","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104360","article-title":"Symptomatic intracerebral hemorrhage after intravenous thrombolysis: predictive factors and validation of prediction models","volume":"28","author":"Nisar","year":"2019","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.clineuro.2012.08.034","article-title":"Atrial fibrillation predicts good functional outcome following intravenous tissue plasminogen activator in patients with severe stroke","volume":"4","author":"Sung","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.03.003","article-title":"Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction","volume":"13","author":"Lindley","year":"2004","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000504191","article-title":"The correlation between atrial fibrillation and prognosis and hemorrhagic transformation","volume":"82","author":"Dang","year":"2019","journal-title":"Eur Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/STROKEAHA.112.650838","article-title":"Impact of atrial fibrillation on outcome in thrombolyzed patients with stroke: evidence from the Virtual International Stroke Trials Archive (VISTA)","volume":"43","author":"Frank","year":"","journal-title":"Stroke"},{"key":"B41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/STROKEAHA.112.676551","article-title":"Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes","volume":"44","author":"Saposnik","year":"","journal-title":"Stroke"},{"key":"B42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/MD.0000000000003054","article-title":"Atrial fibrillation is associated with poor outcomes in thrombolyzed patients with acute ischemic stroke: a systematic review and meta-analysis","volume":"95","author":"Yue","year":"2016"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1007\/s10072-020-04398-2","article-title":"The relationship of leukoaraiosis, haemorrhagic transformation and prognosis at 3 months after intravenous thrombolysis in elderly patients aged \u2265 60 years with acute cerebral infarction","volume":"41","author":"Liu","year":"2020","journal-title":"Neurol Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"106206","DOI":"10.1016\/j.clineuro.2020.106206","article-title":"A 2-point difference of NIHSS as a predictor of acute ischemic stroke outcome at 3 months after thrombolytic therapy","volume":"198","author":"Jantasri","year":"2020","journal-title":"Clin Neurol Neurosurg."},{"key":"B45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3174\/ajnr.A3169","article-title":"Factors influencing clinically meaningful recanalization after IV-rtPA in acute ischemic stroke","volume":"34","author":"Murphy","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/2396987319889468","article-title":"Effect of haemoglobin levels on outcome in intravenous thrombolysis-treated stroke patients","volume":"5","author":"Altersberger","year":"2020","journal-title":"Eur Stroke J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e003019","DOI":"10.1161\/JAHA.115.003019","article-title":"Impact of hemoglobin levels and anemia on mortality in acute stroke: analysis of UK regional registry data, systematic review, and meta-analysis","volume":"5","author":"Barlas","year":"2016","journal-title":"J Am Heart Assoc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1212\/WNL.0b013e31828250ff","article-title":"Sex differences and hemoglobin levels in relation to stroke outcomes","volume":"80","author":"Kimberly","year":"2013","journal-title":"Neurology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pjnns.2015.03.001","article-title":"The impact of anemia on the course and short-term prognosis in patients with first ever ischemic stroke","volume":"49","author":"Lasek-Bal","year":"2015","journal-title":"Neurol Neurochir Pol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"CD007574","DOI":"10.1002\/14651858.CD010995.pub3","article-title":"Endovascular thrombectomy and intra-arterial interventions for acute ischaemic stroke","volume":"6","author":"Roaldsen","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.3390\/jcm10215084","article-title":"Clinical and non-clinical determinants of the effect of mechanical thrombectomy and post-stroke functional status of patients in short and long-term follow-up","volume":"10","author":"Lasek-Bal","year":"2021","journal-title":"J Clin Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/jcm12010356","article-title":"Risk of liver fibrosis is associated with more severe strokes, increased complications with thrombolysis, and mortality","volume":"12","author":"Toh","year":"2023","journal-title":"J Clin Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1103063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T08:30:25Z","timestamp":1677227425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1103063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":52,"alternative-id":["10.3389\/fneur.2023.1103063"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1103063","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"article-number":"1103063"}}